COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03775850
Recruitment Status : Recruiting
First Posted : December 14, 2018
Last Update Posted : July 14, 2020
SCRI Development Innovations, LLC
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Evelo Biosciences, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 19, 2020
Estimated Study Completion Date : December 19, 2020